Open AccessOutcomes of children born to mothers with systemic lupus erythematosus exposed to hydroxychloroquine or azathioprine
Author(s) -
John A. Reynolds,
Mary Gayed,
Munther Khamashta,
Francesca Leone,
Veronica Toescu,
Ian N. Bruce,
Ian Giles,
LeeSuan Teh,
Neil McHugh,
Mohammed Akil,
Christopher J Edwards,
Caroline Gordon
Publication year - 2022
Publication title -
rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.957
H-Index - 173
eISSN - 1462-0332
pISSN - 1462-0324
DOI - 10.1093/rheumatology/keac372
Subject(s) - medicine , hydroxychloroquine , pregnancy , pediatrics , odds ratio , low birth weight , azathioprine , birth weight , logistic regression , intrauterine growth restriction , retrospective cohort study , obstetrics , disease , gestation , infectious disease (medical specialty) , covid-19 , biology , genetics
HCQ and AZA are used to control disease activity and reduce risk of flare during pregnancy in patients with SLE. The aim of this study was to determine the outcomes of children born to mothers with SLE exposed to HCQ or AZA during pregnancy and breast-feeding.